ask="10.00"
ask_size="1000"
average_daily_volume="1678450"
bid="8.85"
bid_size="900"
book_value="0.02"
change="+0.33"
change_from_200_day_moving_average="3.31"
change_from_50_day_moving_average="2.37"
change_from_52_week_high="-0.12"
change_From_52_week_low="6.38"
change_in_percent="+3.92%"
close="8.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.12M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="50464000"
high="8.86"
high_52_weeks="8.86"
last_trade_date="3/9/2017"
last_trade_price="8.74"
last_trade_size="59334"
last_trade_time="4:00pm"
low="7.91"
low_52_weeks="2.36"
market_capitalization="646.37M"
moving_average_200_day="5.43"
moving_average_50_day="6.37"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="7.94"
pe_ratio="N/A"
peg_ratio="-0.57"
percent_change_from_200_day_moving_average="+60.97%"
percent_change_from_50_day_moving_average="+37.24%"
percent_change_from_52_week_high="-1.35%"
percent_change_from_52_week_low="+270.34%"
previous_close="8.41"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="400.48"
price_per_sales="23.60"
revenue="26.35M"
shares_outstanding="73955000"
short_ratio="10.66"
stock_exchange="NMS"
symbol="BCRX"
volume="2662512"
weeks_range_52="2.36 - 8.86"
